
Andrew F. Hundley
Training and career
- Current position Professor of obstetrics and gynecology and director of the Division of Urogynecology and Reconstructive Pelvic Surgery, The Ohio State University Wexner Medical Center, which he started in 20051
- Program director Urogynecology and Reconstructive Pelvic Surgery Fellowship, Ohio State1
- Medical school University of Texas Southwestern Medical School (1998)1
- Residency Obstetrics and gynecology, Brigham and Women's Hospital (1998–2002)1
- Fellowship Female pelvic medicine and reconstructive surgery, University of North Carolina at Chapel Hill (2002–2005)1
- Fellows trained The Ohio State fellowship lists nine graduates from 2018 to 20262
Contributions
His cited work includes national forecasts of pelvic floor disorder prevalence and surgical volume written with Jennifer Wu, and perioperative outcome studies and trials from the Ohio State division.34
- Forecasting pelvic floor disorders in US women (2009). Coauthored a projection from census data and NHANES prevalence estimates in which the number of US women with at least one pelvic floor disorder rises from 28.1 million in 2010 to 43.8 million in 2050.3 Cited on WARWIKI: POP Overview, Clinical Operator Mindset.
- Preoperative laboratory testing before midurethral sling (2019). Senior author of a NSQIP analysis of 12,368 women in which 74.2% had preoperative serum tests and the odds of 30-day complications did not differ with or without testing (adjusted OR 0.98).5
- Continence pessary versus disposable continence device (2022). Coauthored a randomized trial, stopped early at 50 participants, in which 80% of women using a continence pessary and 75% using a disposable intravaginal device reported treatment success at 4 weeks.6 Cited on WARWIKI: Poise Impressa.
Cited on WARWIKI
3 publications with Andrew F. Hundley as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.
- Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050. Obstet Gynecol. 2009;114(6):1278-1283. doi
- Nekkanti S, Wu JM, Hundley AF, et al. A randomized trial comparing continence pessary to continence device (Poise Impressa®) for stress incontinence. Int Urogynecol J. 2022;33(4):861-868. doiCited on: Poise Impressa
- Wu JM, Kawasaki A, Hundley AF, et al. Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050. Am J Obstet Gynecol. 2011;205(3):230.e1-5. doiCited on: POP Overview